Over the past several months, manufacturers pushed technological limits to release products to optimize API and drug product manufacturing processes. Some of these technologies include advancements in ...
The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing. Continuous processing for the production of key building blocks and intermediates for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback